Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Study discourages continued axillary sampling after sentinel lymph node biopsy
November 10th, 2005
A recently published study discourages continued axillary sampling after sentinel lymph node biopsy in staging breast cancer. Scientists writing in the European Journal of Surgery and Oncology reported, "Sentinel lymph node biopsy (SLNB) has become increasingly accepted as a diagnostic method to stage the axilla in breast cancer, selecting women with a positive sentinel node for completion axillary clearance. As SLNB became established, many surgeons supplemented SLNB to sample a minimum of four lymph nodes, on the assumption that the four-node technique is supported by randomized trial data." G. P. H. Gui and colleagues "hypothesised that...
Source: Women's Health Weekly (2005-11-10)
|
